"It's an episodic disorder where people are fine almost all the time, and then have an episode of intense nausea and repetitive vomiting." By comparison, the vomiting associated with gastroparesis tends to occur towards the end of meals or just after someone has finished eating a meal
42 MaggsJ
But the clinical evidence remains incomplete, and understanding where this product fits requires examining what GLP-1 actually does, how traditional agonists work, and what biomimetic alternatives can realistically achieve
People with treatment-resistant hypertension, especially those with co-existing diabetes, obesity, heart failure (HF), or chronic kidney disease (CKD) may particularly benefit from SGLT2-i and GLP-1RA
Once a stable dose was established, patients who stayed consistent achieved cumulative weight loss averaging 20-22% of body weight
10.1681/ASN.2005060638 5